NCT03218969: A reported trial by William Ondo, MD
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03218969 |
|---|---|
| Title | Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 18, 2017 |
| Completion date | Sept. 15, 2018 |
| Required reporting date | Sept. 15, 2019, midnight |
| Actual reporting date | Aug. 28, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |